Effect of annual influenza immunization on antibody response in lung transplant patients

Dopp, John M.; Wiegert, Nicholas A.; Moran, John J. M.; Francois, Mary L.; Radford, Kelly L.; Thomas, Holly; Love, Robert B.; Hayney, Mary S.
June 2009
Progress in Transplantation;Jun2009, Vol. 19 Issue 2, p153
Academic Journal
Background—Influenza viral infections cause significant morbidity and mortality each season. Lung transplant patients may be at higher risk because of their underlying pathophysiology. Although annual immunization is the standard of care, its efficacy remains largely unproven. Previous studies showed poor antibody response to influenza vaccine in lung transplant patients, but no data on the antibody response in consecutive seasons have been published. Methods—We studied antibody responses to influenza vaccine in 122 subjects: 66 lung transplant recipients, 28 control subjects, and 28 patients awaiting lung transplantation. We compared antibody response rates to individual viruses contained in influenza vaccines in consecutive years within the 3 groups. Serum antibody concentrations were measured at baseline and 2 to 4 weeks after vaccination by using the hemagglutination inhibition assay. Log-transformed antibody concentrations and incidence of serconversion and seroprotection were calculated. Results—Median log-transformed antibody responses were similar in consecutive seasons in lung transplant subjects. Incidences of seroprotection and seroconversion did not differ between consecutive seasons in lung transplant recipients. Conclusions—Antibody responses were similar in consecutively measured years in lung transplant subjects. Annual influenza vaccination in lung transplant subjects produces similar immune responses in 2 consecutive years, indicating that these patients are not at significantly increased risk of vaccine failure.


Related Articles

  • Surgical maneuvers for the management of bronchial complications in lung transplantation. de Jesus Peixoto Camargo, José; Camargo, Spencer Marcantonio; Machuca, Tiago Noguchi; Perin, Fabíola Adélia; Schio, Sadi Marcelo; Felicetti, José Carlos // European Journal of Cardio-Thoracic Surgery;Dec2008, Vol. 34 Issue 6, p1206 

    Abstract: Background: Many advances have substantially improved the clinical results of lung transplantation. However, the incidence of bronchial complications is still high, with significant impact on survival and limited interventional strategies for complex cases. Our aim is to evaluate the...

  • Fulminant hyperacute rejection after unilateral lung transplantation. Campo-Cañaveral de la Cruz, Jose Luis; Naranjo, Jose Manuel; Salas, Clara; Varela de Ugarte, Andres // European Journal of Cardio-Thoracic Surgery;Aug2012, Vol. 42 Issue 2, p373 

    Hyperacute rejection (HAR) is a well-known complication in renal and cardiac transplantation, but rare in lung recipients. We present a case of HAR of the lung graft with a fatal outcome of a male patient with preformed class II anti-HLA antibodies.

  • Epidemiology and Management of Infections after Lung Transplantation. Speich, Rudolf; van der Bij, Wire // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS58 

    Discusses the epidemiology and treatment of infectious complications after lung transplantation. Pathogens which typically causes infections after lung transplantation; Microbiologic surveillance of the lung donor and recipients; Double-lung transplantation in patients with lung cystic fibrosis.

  • Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis. Balfour-Lynn, Ian M.; Ryley, Henry C.; Whitehead, Bruce F. // Journal of the Royal Society of Medicine (Supplement);Feb1997, Vol. 90 Issue 31, p59 

    The article presents the case of a child infected with Burkholderia cepacia who underwent lung transplantation and suffered an unusual and serious complication in the post-operative period. The patient, who was diagnosed with cystic fibrosis when she was 3 years old, was immunosuppressed with...

  • Acquired factor VII deficiency in hematopoietic stem cell transplant recipients. Toor, A. A.; Slungaard, A.; Hedner, U.; Weisdorf, D. J.; Key, N. S. // Bone Marrow Transplantation;3/1/2002, Vol. 29 Issue 5, p403 

    Presents a study which identified acquired factor VII (FVII) deficiency in hematopoietic stem cell transplant recipients from 1990 to 1996. Development of veno-occlusive disease in patients; Antibody screening methods fro FVII antibody; Results of the study.

  • Bronchial Dilatation Alone May Not Be Enough for Lung Transplant Complications. Merriman, John // Pulmonary Reviews;Mar2009, Vol. 14 Issue 3, p6 

    The article focuses on a study on the effectiveness of bronchial stenting in lung transplant patients with airway complications, which was reported by Igor Aleksov at the American College of Chest Physicians 2008 Annual International Scientific Assembly. The study by Aleksov and colleagues from...

  • Pepsin Levels Highest in Acute Lung Transplant Rejection.  // Pulmonary Reviews;Jul2007, Vol. 12 Issue 7, p12 

    This article focuses on a study conducted to examine the levels of pepsin in bronchoalveolar lavage (BAL) fluid in the lungs of transplant patients. Results revealed that high levels of pepsin in the BAL fluid, which is a marker for gastric aspiration, is associated with acute rejection of a...

  • Does Lung Transplantation Provide Good Outcomes in Cystic Fibrosis Patients? Edmond, Lissa // Pulmonary Reviews;Sep2008, Vol. 13 Issue 9, p14 

    The article discusses the outcome of lung transplantation in Cystic Fibrosis (CF) patients. It states that among the 176 lung transplantation done in CF group 40% had diabetes mellitus prior to the transplantation and 20% developed diabetes after the transplantation. Veronique Boussaud, MD, from...

  • Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. Holm, A M; Riise, G C; Hansson, L; Brinch, L; Bjørtuft, Ø; Iversen, M; Simonsen, S; Fløisand, Y // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p703 

    Chronic GVHD (cGVHD) associated bronchiolitis obliterans syndrome (BOS) is a serious complication after allo-SCT, and lung transplantation (LTx) may be the ultimate treatment option. To evaluate this treatment, data on all patients with LTx after allo-SCT ever performed in Sweden, Norway,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics